Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.8
177.87%
40%
—
384.67%
60%
—
5 Years
Score5.8
Net Growth177.87%
Net Trend40%
Net Income Consistency—
Rev Growth384.67%
Rev Trend60%
Revenue Consistency—
Abeona Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 10M to $ 5M and net income went from -$ 84M to $ 71M. Revenue increased in 3 of those 5 years; net income in 2.
Across Abeona Therapeutics Inc's full reported history, from 1995 to 2025, revenue grew from $ 2M to $ 5M and net income grew from $ 341K to $ 71M. Revenue increased in 55% of the years measured; net income in 39%.
Abeona Therapeutics Inc currently holds a 20-year HDB Score of 3.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 7.46 | — |
1 Year2025-08-12 | $ 6.38 | 16.93% |
5 Years2021-08-12 | $ 31.25 | -76.13% |
10 Years2016-08-12 | $ 89.50 | -91.66% |
20 Years2006-08-11 | $ 1.1K | -99.32% |
30 Years1996-08-12 | $ 136.08K | -99.99% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 |
|---|---|---|---|---|---|---|
| Price | $ 7.46 | $ 6.38 | $ 31.25 | $ 89.50 | $ 1.1K | $ 136.08K |
| Return | — | 16.93% | -76.13% | -91.66% | -99.32% | -99.99% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 14M | $ 66M | $ 168M |
| 2025 | $ 5M | $ 71M | $ 191M |
| 2024 | $ 0.00 | -$ 63M | $ 97M |
| 2023 | $ 3M | -$ 54M | $ 52M |
| 2022 | $ 1M | -$ 39M | $ 52M |
| 2021 | $ 3M | -$ 84M | $ 45M |
| 2020 | $ 10M | -$ 84M | $ 95M |
| 2019 | $ 0.00 | -$ 76M | $ 129M |
| 2018 | $ 2M | -$ 56M | $ 84M |
| 2017 | $ 837K | -$ 27M | $ 137M |
| 2016 | $ 889K | -$ 21M | $ 69M |
| 2015 | $ 1M | -$ 14M | $ 40M |
| 2014 | $ 925K | -$ 26M | $ 11M |
| 2013 | $ 2M | $ 4M | $ 424K |
| 2012 | $ 4M | -$ 10M | $ 396K |
| 2011 | $ 1M | -$ 2M | $ 2M |
| 2010 | $ 481K | -$ 7M | $ 7M |
| 2009 | $ 352K | -$ 17M | $ 607K |
| 2008 | $ 291K | -$ 31M | $ 2M |
| 2007 | $ 57K | -$ 21M | $ 6M |
| 2006 | $ 550M | -$ 12M | $ 4M |
| 2005 | -$ 1M | $ 474K | |
| 2004 | $ 549K | -$ 10M | $ 2M |
| 2003 | $ 1M | -$ 6M | $ 2M |
| 2002 | $ 1M | -$ 9M | $ 9M |
| 2001 | $ 243K | -$ 6M | $ 20M |
| 2000 | $ 107K | -$ 5M | $ 25M |
| 1999 | $ 15K | -$ 3M | $ 900K |
| 1998 | $ 100K | -$ 3M | $ 1M |
| 1997 | $ 435K | -$ 4M | $ 438K |
| 1996 | $ 167K | -$ 11M | $ 4M |
| 1995 | $ 2M | $ 341K | $ 1M |
Explore beyond ABEO
You're looking at Abeona Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
